J&J

J&J

featured image of J&J Invests $2bn in Game-Changing Cancer Treatments

J&J Invests $2bn in Game-Changing Cancer Treatments

BIOT

🔍 Johnson & Johnson acquires Ambrx for $2bn to boost its ADC pipeline and advance innovative cancer treatments. 💼🌐💉